미국의 척추 수술 시장 규모는 예측기간인 2024년부터 2031년까지 CAGR이 4.19%로 전망되며, 2023년 48억 6,000만 달러로 평가되었고, 2031년에는 68억 달러로 성장할 것으로 예측됩니다. 이 시장의 성장을 뒷받침하는 것은 등과 척추의 손상, 추간판 변성증, 척추 감염, 추간판통 증례 증가, 시장의 주요 진출기업에 의한 신기술 개발을 위한 투자 증가, 낮음 침습 수술에 대한 기호 증가입니다.
Christopher & Dana Reeve Foundation의 추정에 따르면 매년 약 18,000건의 척수 손상 사례가 새롭게 보고되었습니다. 척수 손상으로 인해 척추를 압박할 수 있는 이물질, 골편, 척추 골절 및 추간판 탈장을 제거하기 위해 수술이 필요하기 때문에 이 증가는 미국 척추 수술 시장 수요를 홍보하고 있습니다.
국내에서 비만의 위협이 높아지고 있는 것도 시장 확대를 뒷받침하는 큰 요인입니다. 국립 당뇨병, 소화기 및 신장병 연구소의 추계에 의하면, 미국에서는 성인의 3명에 1명 가까이가 과체중입니다. 이 증가는 과도한 체중이 충격 흡수 추간판의 끼임과 탈장을 일으키고 수술 절차의 필요성을 초래하기 때문에 시장 수요를 뒷받침하고 있습니다.
기술의 진보는 의료 제공업체가 수술의 정확성을 향상시킴으로써 환자의 예후를 개선하고 회복 시간을 단축하는 혁신적인 솔루션을 제공할 것으로 기대되기 때문에 미국에서 척추 수술 수요를 홍보하고 있습니다. 또한 주요 시장 진출 기업은 환자의 편의성을 향상시키고 만성 요통을 관리하는 장비 개발에도 주력하고 있습니다. 2024년 4월, Medtronic Plc는 폐루프 및 충전식 척수 자극기인 Inceptiv의 미국 식품의약국(FDA) 승인을 받았습니다. 인셉티브 척수 자극 장치는 생체 신호를 감지하여 환자의 요구에 맞는 미리 정해진 자극을 유지합니다. 이러한 발전은 시장 확대를 지원하고 유리한 성장 기회를 가져올 것으로 기대됩니다.
이 보고서는 미국의 척추 수술 시장에 대해 조사했으며, 시장 개요와 함께 제품별, 수술별, 적응 질환별, 수술별, 최종 사용자별, 지역별 동향, 시장 진출기업 프로파일 등의 정보를 제공합니다.
United States spine surgery market is projected to witness a CAGR of 4.19% during the forecast period 2024-2031, growing from USD 4.86 billion in 2023 to USD 6.80 billion in 2031. The growth of the market is supported by the rising cases of back and spine injury, degenerative disc disease, spinal infections, and disc pain, rising investments by the key players of the market towards the development of novel technologies, and growing preference for minimally invasive surgeries.
According to the estimates of the Christopher & Dana Reeve Foundation, approximately 18,000 new cases of spinal cord injury are reported every year. This increase is propelling the United States spine surgery market demand as surgical procedures are often necessary for removing foreign objects, fragments of bones, and fractured vertebrae and herniated discs that may compress the spine as a result of spinal cord injuries.
The growing threat of obesity in the country is another major factor supporting the expansion of the market. According to the estimates of the National Institute of Diabetes and Digestive and Kidney Diseases, nearly 1 in 3 adults in the United States are overweight. This rise bolsters the market demand as excessive weight can cause the shock-absorbing discs to become pinched or herniated, resulting in the requirement for surgical procedures.
Technological Advancements Support Market Expansion
Technological advancements are propelling the demand for spine surgeries in the United States as they are expected to offer innovative solutions that allow healthcare providers to enhance patient outcomes and decrease recovery time by improving surgical precision. The key market players are also focusing on developing devices to improve patient convenience and manage chronic back pain. In April 2024, Medtronic Plc received approval from the US Food and Drug Administration (FDA) for their closed-loop and rechargeable spinal cord stimulator, Inceptiv. The inceptive spinal cord stimulators maintain the prescribed stimulation tailored to the patient's requirements by sensing biological signals. Such developments are expected to support market expansion and provide lucrative growth opportunities.
Increasing Cases of Spinal Cord Injury Bolster Market Demand
The rising cases of spinal cord injuries in the United States are expected to provide lucrative growth opportunities to the market. As per the estimates of the Christopher & Dana Reeve Foundation, approximately 302,000 individuals are living with spinal cord injury in the United States. This increase is propelling the requirement for spine surgeries in the countries as they are required to keep the bones in the proper position while they are undergoing healing. The results of spinal cord injuries often vary depending upon the location and type of the injury and can result in slowing of autonomic nerve function and loss of sensory and motor functions, among others.
Growing Preference for Minimally Invasive Procedures Boosts the Market
The growing preference for minimally invasive spine surgeries among patients can be attributed to their increasing awareness about the various advantages offered by them including less pain after the procedure due to limited tissue and muscle damage, decreased loss of blood, and reduced risk of infection. Due to the rising number of minimally invasive spine surgery procedures, the key players of the market are actively investing towards the development of devices that enhance the convenience of the surgeons and ensure the smooth completion of the surgery. In April 2023, Orthofix Medical Inc. announced the launch of two access retractor systems for minimally invasive spine procedures. The Fathom Pedicle-Based Retractor System and Lattus Lateral Access System expanded Orthofix's offerings of access solutions for addressing the various requirements associated with minimally invasive procedures. The Lattus system addresses the important areas of lateral spine surgery, including plate fixation, removal or preparation of the disc, interbody placement, and easy access to the spine.
Spinal Fusion Devices Hold Significant Share of the Market
The spinal fusion device helps heal fusions and provides additional spine stability. They also aid in correcting malalignment, enhancing spinal fusion, and improving the overall stability of the spine by restricting movement in the treated spinal segment, securing bone graft material, and serving as a medium to replace the spinal disc. Due to the rising requirement for spinal fusion devices, the key players of the market are increasingly focusing on new product launches, further aiding the growth of the segment. In November 2023, in the United States, Orthofix Medical Inc. commercially launched their WaveFormL system, which is intended for lateral lumbar interbody fusion procedures.
Future Market Scenario (2024-2031F)
As per the United States spine surgery market analysis, the market demand is expected to increase significantly in the coming years due to rising obesity in the country and increasing investments by the key market players towards the introduction of new devices and systems. Boston Scientific Corporation is conducting an interventional study for compiling the real-world outcomes of the Superion Indirect Decompression System (IDS) in routine clinical trials, when the directions of use are followed. The study is expected to conclude in June 2029. Additionally, the growing awareness about spine health and the availability of different devices for managing and treating various conditions is also expected to support the market's expansion in the United States.
Key Players Landscape and Outlook
The growth of the United States spine surgery market is supported by the increasing investments by the key players of the market towards the introduction of novel products and technologies in the country. In January 2024, Abbott Laboratories announced that their Liberta RC deep brain stimulation (DBS) system was approved by the United States Food and Drug Administration (U.S. FDA). The system features NeuroSphere Virtual Clinic, which supports the programming of the system remotely. The Liberta RC DBS system is a first-of-its-kind technology that allows patients in the United States to receive new treatment settings and communicate with their doctors remotely. The company developed the system after research showcases that Abbott DBS users in the United States travel over 150 miles, on average, to meet with a movement disorder specialist. Such introductions and approvals are expected to enhance consumer convenience and aid companies in expanding their customer base in the country.
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.